ZLAB Q2 2023 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$69M+42.9% YoY

Gross Profit

$45M65.5% margin

Operating Income

-$90M-130.0% margin

Net Income

-$121M-175.6% margin

EPS (Diluted)

$-12.50

QoQ Revenue Growth

+9.7%

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$61M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$174M

Stockholders' Equity

$932M

Cash & Equivalents

$859M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$48M	+42.9%
Gross Profit	$45M	$31M	+46.6%
Operating Income	-$90M	-$99M	+9.3%
Net Income	-$121M	-$138M	+12.4%

Revenue Segments

Zejula

$43M62%

Optune

$14M20%

Qinlock

$8M11%

Nuzyra

$5M7%